Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns
-
- Orla Cunningham
- UltraHuman Eight Limited, C/o Kreston Reeves Llp, Kent, UK
-
- Martin Scott
- Department of Biopharm Discovery, GlaxoSmithKline Research & Development, Hertfordshire, UK
-
- Zhaohui Sunny Zhou
- Department of Chemistry and Chemical Biology, Barnett Institute for Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts, USA
-
- William J.J. Finlay
- UltraHuman Eight Limited, C/o Kreston Reeves Llp, Kent, UK
Journal
-
- mAbs
-
mAbs 13 (1), e1999195-, 2021-01-01
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1360861711979736448
-
- ISSN
- 19420870
- 19420862
-
- Data Source
-
- Crossref